There are 3 major forms of degenerative dementia; Alzheimer disease (AD), Dementia with Lewy bodies (DLB), and Frontotemporal Dementias (FTD). Convergent clinical, pathologic, and genetic data indicate that these degenerative dementias have different mechanisms of pathogenesis. It is likely that different treatments will be needed to alter the course of these disorders. Appropriate application of treatments will require precise and early diagnosis. Precise, early diagnosis would be very useful now to improve clinical trial performance. Improved precision of initial diagnosis would also be valuable for present clinical practice. Certain differentiation of these entities is possible with postmortem evaluations only. Clinical criteria exist to guide ante-mortem diagnosis but these criteria are imprecise. Differentiating DLB and FTD from AD is particularly difficult, especially in individuals with mild-early dementia. Imaging methods may improve the precision of initial diagnosis. We found that quantifying nigrostriatal dopamine terminals robustly differentiates AD and DLB. FTD may be differentiated from AD and DLB by distinctive patterns of regional cortical hypometabolism. We have developed a method, [11C]dihydrotetrabenazine positron emission tomography (DTBZ-PET), that quantifies nigrostriatal terminal density and assesses regional cortical perfusion as a faithful analogue of regional cortical metabolism. Our preliminary data suggests that this method will permit early, accurate differentiation of AD, DLB, and FTD. Our goal is to develop an imaging method to permit early and accurate differentiatal diagnosis of early mild dementia. We propose a prospective evaluation of the ability of DTBZ-PET to differentiate the 3 major degenerative dementias in subjects with early-mild dementia. Our hypothesis is that the results of DTBZ-PET imaging in subjects with mild, early dementia will predict their evolution into clinically distinguished AD, FTD, and DLB. Our first specific aim is to determine nigrostriatal terminal density and patterns of regional cortical perfusion in a cohort of well characterized subjects with early-mild dementia. Our second specific aim is respectively to follow and characterize this cohort with standardized clinical and psychometric evaluations. Our third specific aim is to correlate the clinically and psychometrically established diagnoses with diagnoses predicted by DTBZ-PET. If successful, these studies would strongly support the use of DTBZ-PET imaging or similar methods in the evaluation of early dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG008671-16A1
Application #
6933396
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2005-06-01
Project End
2010-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
16
Fiscal Year
2005
Total Cost
$125,000
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Michaud, Tzeyu L; High, Robin; Charlton, Mary E et al. (2017) Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord 31:209-217
Monin, Joan K; Poulin, Michael J; Brown, Stephanie L et al. (2017) Spouses' daily feelings of appreciation and self-reported well-being. Health Psychol 36:1135-1139
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Cary, Brian P; Brooks, Allen F; Fawaz, Maria V et al. (2016) Synthesis and Evaluation of [(18)F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. ACS Chem Neurosci 7:391-8
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17

Showing the most recent 10 out of 274 publications